Anixa Biosciences, Inc. · NASDAQ:ANIX

Anixa Biosciences — Copytele — Investor Presentation (October 2012)

13 slides from Anixa Biosciences's investor presentation, Oct 10, 2012

  1. Slide 1: CopyTele Inc. October 2012

    C...T.... I. October 2012

  2. Slide 2: Forward Looking Statement

    Forward Looking Statement Forward-Looking Statements: Statements that are not historical fact may be considered forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward. looking statements are not statements of historical facts, but rather reflec

  3. Slide 3: CTI - Overview

    CTI - Overview COPY: OTC Pioneering inventions — encryption, advanced flat panel displays, telecom Old business model — partner with manufacturers to commercialize technologies — Unsuccessful business model masked world class technologies — Protected by 55 U.S. Patents and 11 pending applications Ne

  4. Slide 4: Patent Assertion Companies

    Patent Assertion Companies Acacia Research ACTG $1.68 InterDigital Iocc $1.48 Parker Vision PRKR $189 Rambus RMBS $5a5M Universal Display PANL $1.88 Virnetx VHC $1.428 Vringo VRNG $111M

  5. Slide 5: Hidden Patent Value

    Hidden Patent Value SBillions ? Nortel Mototols Mobile — Rim Kodak

  6. Slide 6: New CTI Management Team

    New CTI Management Team Dr. Amit Kumar, Advisor Experienced Scientist Investor and Executive + Board Member of Acacia Research Corporation from 2002-2008 + BA-Occidental College, Ph.0. Stanford University and Caltech, Post-doc Harvard University Robert A. Berman, President and CEO Entrepreneur, atto

  7. Slide 7: Market Capitalization ($ in Millions)

    Market Capitalization ($ in Millions) The first time we tried this... $2,500 $2,000 8 $1,000 $500 2003 © -2004-«=«2005 | 2006« «200720082009 20102018 Date 2012

  8. Slide 8: Market Capitalization ($ in Millions) - This time...

    (Market Capitalization (§ in Millions) This time... $2500 $2,000 8 i $0.22 $0 2012 2013 2018 2015 201620172018 201920202021 Date

  9. Slide 9: Patent Assertion

    . . . Patent Assertion Low overhead — No development or manufacturing costs Variable cost structure — Acquisition costs (fixed, variable) — Legal fees (fixed, variable) High gross margins — Up to 70% Modest cash requirements — Acquisitions — War chest

  10. Slide 10: Patent Assertion: 2005 - July 2012

    Patent Assertion: 2005 - July 2012 x Patent Cases Trial Verdicts 3% Settlement ™ Defendants @Trial Plaintiffs Other *Damages 150 7—a55 92 100 50 11 0 = Under Som S1oM-$100M S100N4.$18 Ov “average Verdict $46.7M

  11. Slide 11: CTI Patented Technologies

    CTI Patented Technologies * Email encryption C — 12 patents — Required by HIPPA, HITEC, GLBA, and other federal and state privacy statutes — Email encryption market - $588M by 2013 — 16 patents — Fundamental technology driving eReader market — eReader device sales to exceed $2.5B by 2013 * Electroph

  12. Slide 12: CTI Patented Technologies

    CTI Patented Technologies * Nano Field Emission Displays — 23 patents — Low power, high resolution, better viewing angles, cheaper manufacturing — Global flat panel display market - $110B by 2017 * MEMS- Micro Electro Mechanical Systems — 3 patents (a) — Low power with video capability — Potential n

  13. Slide 13: CTI - Next Steps

    CTI - Next Steps Strengthen the balance sheet Re-evaluate existing licenses and encumbrances Implement patent assertion strategy Use platform to acquire other patents

Copytele — Investor Presentation (October 2012) on 6ix